- Home
- BCRX vs CDRE Comparison
BCRX vs CDRE Comparison
Compare BCRX & CDRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- CDRE
- Stock Information
- Founded
- BCRX 1986
- CDRE 2012
- Country
- BCRX United States
- CDRE United States
- Employees
- BCRX N/A
- CDRE N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- CDRE Industrial Specialties
- Sector
- BCRX Health Care
- CDRE Health Care
- Exchange
- BCRX Nasdaq
- CDRE Nasdaq
- Market Cap
- BCRX 1.4B
- CDRE 1.5B
- IPO Year
- BCRX 1994
- CDRE 2021
- Fundamental
- Price
- BCRX $7.31
- CDRE $43.18
- Analyst Decision
- BCRX Strong Buy
- CDRE Buy
- Analyst Count
- BCRX 11
- CDRE 3
- Target Price
- BCRX $19.55
- CDRE $35.33
- AVG Volume (30 Days)
- BCRX 7.0M
- CDRE 301.9K
- Earning Date
- BCRX 11-03-2025
- CDRE 11-04-2025
- Dividend Yield
- BCRX N/A
- CDRE 0.88%
- EPS Growth
- BCRX N/A
- CDRE N/A
- EPS
- BCRX N/A
- CDRE 0.93
- Revenue
- BCRX $557,506,000.00
- CDRE $572,607,000.00
- Revenue This Year
- BCRX $41.57
- CDRE $12.55
- Revenue Next Year
- BCRX $6.25
- CDRE $7.70
- P/E Ratio
- BCRX N/A
- CDRE $46.37
- Revenue Growth
- BCRX 45.85
- CDRE 7.66
- 52 Week Low
- BCRX $6.00
- CDRE $27.07
- 52 Week High
- BCRX $11.31
- CDRE $44.29
- Technical
- Relative Strength Index (RSI)
- BCRX 51.20
- CDRE 74.13
- Support Level
- BCRX $6.44
- CDRE $42.49
- Resistance Level
- BCRX $6.92
- CDRE $43.78
- Average True Range (ATR)
- BCRX 0.30
- CDRE 1.54
- MACD
- BCRX 0.09
- CDRE 0.09
- Stochastic Oscillator
- BCRX 95.62
- CDRE 83.46
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About CDRE Cadre Holdings Inc.
Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets. The Company's equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Its operations are comprised of two reportable segments: Products and Distribution.